141 related articles for article (PubMed ID: 3180633)
1. Theophylline pharmacokinetics in normal elderly subjects.
Shin SG; Juan D; Rammohan M
Clin Pharmacol Ther; 1988 Nov; 44(5):522-30. PubMed ID: 3180633
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.
Brion N; Naline E; Beaumont D; Pays M; Advenier C
Br J Clin Pharmacol; 1989 Mar; 27(3):391-5. PubMed ID: 2497767
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
Knoppert DC; Spino M; Beck R; Thiessen JJ; MacLeod SM
Clin Pharmacol Ther; 1988 Sep; 44(3):254-64. PubMed ID: 3046811
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of interaction between theophylline and mexiletine.
Ueno K; Miyai K; Kato M; Kawaguchi Y; Suzuki T
DICP; 1991; 25(7-8):727-30. PubMed ID: 1949927
[TBL] [Abstract][Full Text] [Related]
5. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
Monks TJ; Caldwell J; Smith RL
Clin Pharmacol Ther; 1979 Oct; 26(4):513-24. PubMed ID: 487699
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
7. Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.
Bonnacker I; Berdel D; Süverkrüp R; von Berg A
Eur J Clin Pharmacol; 1989; 36(2):145-50. PubMed ID: 2721539
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluconazole on theophylline disposition in humans.
Konishi H; Morita K; Yamaji A
Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
Kim EJ; Suh OK; Lee MG
Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients.
Tateishi T; Asoh M; Yamaguchi A; Yoda T; Okano YJ; Koitabashi Y; Kobayashi S
Pediatr Res; 1999 Jan; 45(1):66-70. PubMed ID: 9890610
[TBL] [Abstract][Full Text] [Related]
11. Theophylline pharmacokinetics in advanced age.
Antal EJ; Kramer PA; Mercik SA; Chapron DJ; Lawson IR
Br J Clin Pharmacol; 1981 Nov; 12(5):637-45. PubMed ID: 7332727
[TBL] [Abstract][Full Text] [Related]
12. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
Kuh HJ; Shim CK
Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
[TBL] [Abstract][Full Text] [Related]
14. The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man.
Monks TJ; Lawrie CA; Caldwell J
Biopharm Drug Dispos; 1981; 2(1):31-7. PubMed ID: 7236869
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and theophylline clearance and metabolism.
Grygiel JJ; Birkett DJ
Clin Pharmacol Ther; 1981 Oct; 30(4):491-6. PubMed ID: 7285483
[TBL] [Abstract][Full Text] [Related]
16. Non-linear elimination processes of theophylline.
Gundert-Remy U; Hildebrandt R; Hengen N; Weber E
Eur J Clin Pharmacol; 1983; 24(1):71-8. PubMed ID: 6832205
[TBL] [Abstract][Full Text] [Related]
17. Lack of clinically important interaction between erythromycin and theophylline.
Hildebrandt R; Gundert-Remy U; Möller H; Weber E
Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
[TBL] [Abstract][Full Text] [Related]
18. Measurement of excretion characteristics of theophylline and its major metabolites.
Jonkman JH; Tang D; Upton RA; Riegelman S
Eur J Clin Pharmacol; 1981; 20(6):435-41. PubMed ID: 7286053
[TBL] [Abstract][Full Text] [Related]
19. Effects of enoxacin on renal and metabolic clearance of theophylline in rats.
Nadai M; Hasegawa T; Kuzuya T; Muraoka I; Takagi K; Yoshizumi H
Antimicrob Agents Chemother; 1990 Sep; 34(9):1739-43. PubMed ID: 2285287
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions affecting fluoroquinolones.
Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
